AS · grundat 2016OsloModerbolag · 1 dotterbolaghette HELSEINKUBATOR AS →2016
Brreg · companies
personalserien visas efter två registerändringar
Roller från Brreg, visas endast för affärskontakt. Inget födelsedatum visas eller exporteras (ändamålsbegränsning, GDPR Art. 6(1)(f)).
Brreg · company_people
5 registrerade roller
| Daglig leder | Aksel Tunold | 2025-03-11 | |
| Styrets leder | Hans-Peter Hygen Daae Flera styrelser | 2026-01-09 | |
| Styremedlem | Ole Kristian Hjelstuen | 2026-01-09 | |
| Styremedlem | Guro Bjøntegaard Flera styrelser | 2026-01-09 | |
| Styremedlem | Håvard Selby Ebbestad Flera styrelser | 2026-01-09 |
| 2024 | 2025 | ||
|---|---|---|---|
| Omsättning | kr 15.5M | kr 12.6M | |
| Rörelseresultat | kr 138k | kr -883k | |
| Nettoresultat | kr -147k | kr -1.4M |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| Omsättning | kr 15.5M | kr 12.6M | |||||
| Rörelseresultat | kr 138k | kr -883k | |||||
| Nettoresultat | kr -147k | kr -1.4M |
Totala tillgångar kr 6.54MEget kapital kr 1.92M
Regnskapsregisteret · company_revenue · RÅ2025 (företag)
registerlogg · pengar
| 2026-06-23 | reg | accounts_filed: sisteInnsendteAarsregnskap | 2024 -> 2025 |
| 2024 | 2025 | ||
|---|---|---|---|
| OSLOTECH AS | 33 | 67 | — |
| INVEN2 AS | 33 | 33 | — |
| NORWAY HEALTH TECH | 33 | — | — |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| OSLOTECH AS | 33 | 33 | 33 | 33 | 33 | 67 | — |
| INVEN2 AS | 33 | 33 | 33 | 33 | 33 | 33 | — |
| NORWAY HEALTH TECH | 33 | 33 | 33 | 33 | 33 | — | — |
Aksjonærregisteret · company_ownership · 2025 · båda riktningar
registerlogg · ägare
| 2025-12-31 | ägare− | NORWAY HEALTH TECH exited (held 33.3 pct) |
Inga registrerade anbudsvinster.
Relevanta öppna upphandlingar — matchade · NACE 70.200 ↔ CPVprenumeranter förfinar träffar med nyckelord per företag
matchning av öppna upphandlingar (NACE ↔ CPV) väntar på Intelligos vy för öppna upphandlingar
Doffin/TED · company_tender_wins · 2026-08-14
Inga jobbannons registrerade de senaste 12 månaderna.
NAV Arbeidsplassen · company_job_ad_months
Koncernomsättning kr 13.9MKoncernresultat kr -2.49MVunna anbud 0Sammanräknat över moderbolaget + 1 dotterbolag — Aleap Ventures AS ensamt är kr 1.31M.
sammanräknad uppskattning · inlämnad konsernregnskap finns ännu inte i Intelligo
| Aleap Ventures AS | 100% | Fund management activities | kr 1.31M |
| Aleap Invest i AS | 40% | ||
| Aristeia AS | 5.3% | ||
| 4.3% | |||
| Bio-Me AS | 3.8% | ||
| Age Labs AS | 2.6% | ||
| Pacertool AS | 1.2% | ||
| Oivi AS | 0.9% | ||
| Cimon Medical AS | 0.6% | ||
| Cardinor AS | 0.3% |
Aksjonærregisteret · company_ownership · 2025 · båda riktningar
FY2025revision: Inga reservationerBDO AS3 årsarbetskraftersignerad: Ole Kristian Hjelstuen, Guro Bjøntegaard, Hans-Peter Hygen Daae, Håvard Selby Ebbestad, Aksel Tunold
Regnskapsregisteret (årsberetning) · company_annual_reports
17 noteringar från förvaltningsberättelsen
| Audit opinion | BDO AS issued an unmodified audit opinion on the 2025 financial statements of Aleap AS. | “Vi har revidert arsregnskapet til Aleap AS.” |
| Going concern | The board states equity is adequate and that there is good reason to assume continued operations. | “Egenkapitalerforsvarlig,og deteretter dette mene god grunn tilaha en fortsatt drift iselskapet.Det er” |
| Ownership | Oslotech AS holds 60 000 shares, equal to 66.7% of capital and votes. | “OSLOTECH AS 60 000 66,7 66,7” |
| Share capital | Share capital consists of 90 000 G-shares of nominal value 1.0. | “G-aksjer 90 000 1,0 00006” |
| Staff numbers | The company employed 3 man-years in 2025. | “Selskapet har i 2025 sysselsatt 3 arsverk.” |
| Remuneration | Total payroll costs were NOK 4 504 250 in 2025 against NOK 6 319 241 in 2024. | “Sum 4 504 250 6 319 241” |
| Subsidiary | Aleap AS owns 100% of the shares and votes in Aleap Ventures AS, based in Oslo. | “Aleap AS eier 100% av aksjene iAleap Ventures AS, som gir Aleap AS 100% av stemmene iselskapet.Aleap” |
| Impairment | Shares were written down by NOK 5 719 576 in 2025, all of them financed through the pre-seed scheme. | “nedskrivning i 2025 pa kr 5 719 576.Alle aksjene som er skrevet ned er fulfinansiert via pre-” |
| Loan or financing | The pre-seed loan outstanding at 31.12.2025 amounts to NOK 7 999 992. | “Lanet pr. 31.12.25 er kr. 7 999 992” |
| Loan or financing | The loan is interest-free and without repayment terms under the pre-seed scheme. | “Lanet skal vaere rente og avdragsfritt, og er et lan under presakornordningen.” |
| Pledge or guarantee | If investment projects fail and are realised at a loss, the loans from Investinor are cancelled, so they are treated as a contingent obligation. | “Dersom investeringsprosjektene ikke lykkes,ogrealiseres med tap,slettes lanene fraInvestinor.Lanene” |
| Dividend | No dividend; the loss of NOK 1 395 951 was transferred to other equity. | “Avsatt til annen egenkapital Sum overforinger -1 395 951 -1 395 951 -147 211 -147 211” |
| Deferred tax | A deferred tax asset of NOK 246 072 (22%) is recognised at year end 2025 against NOK 54 203 in 2024. | “Utsatt skattefordel (22 %) -246 072 -54 203 191 869” |
| Related party | The company has a loan of NOK 51 079 to an associated company/jointly controlled entity. | “Lantiltilknyttet selskapogfelleskontrollert virksomhet 51 079 o” |
| Related party | Long-term group debt of NOK 599 479 was recognised at 31.12.2025 (nil in 2024). | “Langsiktig konserngjeld 12 599 479 o” |
| Other | Audit fee expensed for 2025 was NOK 168 199. | “Kostnadsfort revisjonshonorar for 2025 utgjor kr 168 199.” |
| Other | Restricted funds on the tax withholding account amount to NOK 211 844. | “Innestaende midler pa skattetrekkskonto (bundne midler) er pa kr. 211 844.” |
registrerad 2016-08-18
Brreg · companies
registerlogg · 19 händelser
| 2026-06-23 | reg | accounts_filed: sisteInnsendteAarsregnskap | 2024 -> 2025 |
| 2025-12-31 | rapport | Audit opinion | BDO AS issued an unmodified audit opinion on the 2025 financial statements of Aleap AS. — Vi har revidert arsregnskapet til Aleap AS. |
| 2025-12-31 | rapport | Going concern | The board states equity is adequate and that there is good reason to assume continued operations. — Egenkapitalerforsvarlig,og deteretter... |
| 2025-12-31 | rapport | Ownership | Oslotech AS holds 60 000 shares, equal to 66.7% of capital and votes. — OSLOTECH AS 60 000 66,7 66,7 |
| 2025-12-31 | rapport | Share capital | Share capital consists of 90 000 G-shares of nominal value 1.0. — G-aksjer 90 000 1,0 00006 |
| 2025-12-31 | rapport | Staff numbers | The company employed 3 man-years in 2025. — Selskapet har i 2025 sysselsatt 3 arsverk. |
| 2025-12-31 | rapport | Remuneration | Total payroll costs were NOK 4 504 250 in 2025 against NOK 6 319 241 in 2024. — Sum 4 504 250 6 319 241 |
| 2025-12-31 | rapport | Subsidiary | Aleap AS owns 100% of the shares and votes in Aleap Ventures AS, based in Oslo. — Aleap AS eier 100% av aksjene iAleap Ventures AS, som g... |
| 2025-12-31 | rapport | Impairment | Shares were written down by NOK 5 719 576 in 2025, all of them financed through the pre-seed scheme. — nedskrivning i 2025 pa kr 5 719 57... |
| 2025-12-31 | rapport | Loan or financing | The pre-seed loan outstanding at 31.12.2025 amounts to NOK 7 999 992. — Lanet pr. 31.12.25 er kr. 7 999 992 |
| 2025-12-31 | rapport | Loan or financing | The loan is interest-free and without repayment terms under the pre-seed scheme. — Lanet skal vaere rente og avdragsfritt, og er et lan u... |
| 2025-12-31 | rapport | Pledge or guarantee | If investment projects fail and are realised at a loss, the loans from Investinor are cancelled, so they are treated as a contingent obli... |
| 2025-12-31 | rapport | Dividend | No dividend; the loss of NOK 1 395 951 was transferred to other equity. — Avsatt til annen egenkapital Sum overforinger -1 395 951 -1 ... |
| 2025-12-31 | rapport | Deferred tax | A deferred tax asset of NOK 246 072 (22%) is recognised at year end 2025 against NOK 54 203 in 2024. — Utsatt skattefordel (22 %) -246 0... |
| 2025-12-31 | rapport | Related party | The company has a loan of NOK 51 079 to an associated company/jointly controlled entity. — Lantiltilknyttet selskapogfelleskontrollert vi... |
| 2025-12-31 | rapport | Related party | Long-term group debt of NOK 599 479 was recognised at 31.12.2025 (nil in 2024). — Langsiktig konserngjeld 12 599 479 o |
| 2025-12-31 | rapport | Other | Audit fee expensed for 2025 was NOK 168 199. — Kostnadsfort revisjonshonorar for 2025 utgjor kr 168 199. |
| 2025-12-31 | rapport | Other | Restricted funds on the tax withholding account amount to NOK 211 844. — Innestaende midler pa skattetrekkskonto (bundne midler) er pa kr... |
| 2025-12-31 | ägare− | NORWAY HEALTH TECH exited (held 33.3 pct) |
Skiwo · company_events